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Abstract There is a very little information about the
protective effect of lycopene (LYC) against hepatic
ischemia–reperfusion injury. The present study was
designed to examine the possible protective effect of
the strong antioxidant and anti-inflammatory agent,
LYC, on hepatic ischemia/reperfusion injury. For this
purpose, rats were subjected to 45 min of hepatic
ischemia followed by 60 min of reperfusion period.
LYC at the doses of 2.5 and 5 mg/kg body weight (bw)
were injected intraperitoneally, 60 min prior to ische-
mia. Upon sacrification, hepatic tissue samples were
used for the measurement of catalase (CAT) activity
and malondialdehyde (MDA) levels. Also, aspartate
aminotransferase (AST), alanine aminotransferase
(ALT) and lactate dehydrogenase (LDH) were assayed
in serum samples. As a result of the use of LYC at the
doses of 2.5 and 5 mg/kg bw; while improvements of
the ALT, AST, LDH and MDA values were partial and
dose-dependent, the improvement of CAT activity
was total and dose-independent (p \ 0.05). Our find-
ings suggest that LYC has a protective effect against
ischemia/reperfusion injury on the liver.
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Introduction
Liver ischemia–reperfusion (I/R) is a serious patho-
logic process encountered in a number of clinical
syndromes including liver transplantation, liver resec-
tion, trauma and hemorrhagic shock (Okatani et al.
2003; Jia et al. 2008; Bi et al. 2008). Ischemia and
perfusion leads to oxidative stress that is characterized
by an imbalance between reactive oxygen species
(ROS) and the anti-oxidative defense system. The
reperfusion of ischemic tissue has been shown to
worsen acute ischemic injuries by releasing ROS
(Akman et al. 2010).
Accumulation of ROS may easily be dealt with by
endogenous anti-oxidative systems, such as catalase
(CAT), superoxide dismutase (SOD) (Wang et al.
2011; Polat et al. 2008), glutathione peroxidase (GPx)
and glutathione (GSH), because they already exist at
low concentrations in the liver. Generated ROS, in
turn, provoke damage to lipids and proteins eventually
leading to liver damage. For these reasons, treatment
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with exogenous antioxidants, particularly in the early
stages of reperfusion, significantly reduces liver I/R
injury (Wang et al. 2011).
Carotenoids prevent oxidative injury in biological
systems such as damage to DNA molecules, proteins,
cell membrane, lipids and other structures in the cell.
Lycopene (LYC) is a ‘‘nonprovitamin A carotenoid’’
(Aydin and C¸elik 2012). The chemical structure of
LYC (Fig. 1) has a 40-carbon acyclic carotenoid with
11 linearly arranged conjugated double bonds (Tang
et al. 2007). LYC is one dietary carotenoid found in
fruits such as papaya, fresh ripe tomato, guava,
grapefruit and watermelon (Yaping et al. 2002). This
carotenoid is a potent anticancer, anti-inflammatory,
antiproliferative, neuroprotective, cognition enhancer
and hypocholesterolemic agent (Kuhad et al. 2008).
In addition, it has been ranked as being most
potent among the following antioxidants: lycopene [
a-tocopherol [ a-carotene [ b-cryptoxanthin [ zea-
xanthin = b-carotene [ lutein. Moreover, several
studies suggest that LYC is a more potent scavenger
of oxygen radicals than other major dietary carote-
noids (Alshatwi et al. 2010). LYC, because of its high
number of conjugated double bonds, has been declared
to exhibit higher singlet oxygen quenching ability
compared to b-carotene or a-tocopherol and to act as a
potent antioxidant, preventing the oxidative damage of
critical biomolecules including lipids, proteins and
DNA (Rios et al. 2009; Palozza et al. 2010). Also,
LYC has been under marked investigation for its anti-
oxidant benefits in treating various chronic human
diseases like cancer, cardiovascular diseases, osteo-
porosis and diabetes (Kuhad et al. 2008).
To our knowledge, there is a very little information
about this carotenoid against hepatic I/R injury in rats.
For this aim, We aimed to examine the role of LYC at
the doses of 2.5 and 5 mg/kg bw on hepatic I/R-
induced tissue damage by measurement of biochem-
ical parameters in liver homogenates (MDA levels and




Twenty-eight adult male Sprague-Dawley rats (weigh-
ing 240–290 g) were provided from TICAM (Medical
and Surgical Experimental Research Centre, Eskisehir
Osmangazi University) and housed in polycarbonate
cages in an air-conditioned room (22 ± 2 C) with a
12 h light:12 h dark cycle (0700 on, 1900 hours off);
standard rat feed and water were provided ad libitum.
The rats were allowed to acclimatize to the laboratory
environment for 7 days before the start of the
experiment.
All procedures were conducted in conformity with
the Institutional Ethical Committee for Animal Care
and use at Eskisehir Osmangazi University (protocol
number: 06-28/28) and the international guidelines on
the ethical use of animals (NIH publications no:
80-23).
Drug and reagent
Lycopene was purchased from Sigma (St. Louis, MO,
USA; catalogue number: L9879-1 MG).
Surgery
Under xylazine (10 mg/kg bw) and ketamine (70 mg/
kg bw) anaesthesia, a minimal laparotomy was made
using minimal dissection. Total hepatic ischemia was
induced for 45 min by clamping the hepatic artery, the
portal vein, and the bile duct using a vascular clamp.
During the period of ischemia 0.5 ml of saline was
given intraperitonally and then subjected to reperfu-
sion for 60 min (Sener et al. 2003).
Experimental groups
A total of 28 rats were divided into 4 groups (n = 7 per
group); Group I: Normal control animals (NC), Group
II: I/R control animals (IR-C), Group III: I/R animals
given lycopene at the dose of 2.5 mg/kg bw (LYC-2.5)
Group IV: I/R animals given lycopene at the dose of
5 mg/kg bw (LYC-5). Lycopene dissolved in olive oil
(2 ml/kg volume) was injected intraperitonally 60 min
before ischemia. Group II (I/R) was injected with olive
oil (2 ml/kg volume) by the same way.
Fig. 1 Chemical structure of lycopene
488 Cytotechnology (2015) 67:487–491
123
Biochemical analysis
In this study, biochemical investigations were made
in liver tissue and serum. The rats were sacrificed
at 60 min of reperfusion by slight ether anaesthesia.
Trunk blood samples were collected by cardiac
puncture. As markers of hepatocellular injury
serum ALT, AST and LDH levels were determined
to assess liver functions. ALT, AST and LDH
levels in serum were immediately measured with a
commercial kit (Biolabo, Maizy, France) using an
auto analyzer (Crony Instruments, Airone 200 RA,
Rome, Italy). The serum ALT, AST and LDH were
expressed as ‘‘U/l’’.
MDA was measured by thiobarbituric acid reaction
as a lipid peroxidation product according to the
method of Uchiyama and Mihara (1978). CAT activity
was determined using ammonium molybdate-hydro-
gen peroxide reaction as described previously by Goth
(1991). The amount of total protein in tissue was
measured with a total protein kit that was prepared
according to the Biuret method. MDA, CAT, and total
protein absorbance were determined by means of
Shimadzu UV-1601 digital spectrophotometer (Shi-
madzu Corp. Kyoto, Japan). The hepatic MDA level
and CAT activity were expressed as ‘‘nmol/g protein’’
and ‘‘KU/g’’, respectively.
Statistical analysis
Results were expressed as mean ± SD (Standard
Deviation). The intergroup variation was measured
by one-way analysis of variance (Anova) followed by
Tukey’s test to assess the significance. Statistical
significance was considered at ‘‘p \ 0.05’’. The sta-
tistical analysis was done using the SPSS Statistical
Software version 12.
Results
As shown in Table 1; the use of LYC at the doses of
2.5 and 5 mg/kg bw significantly reduced (p \ 0.05)
the ALT, AST, LDH and MDA values after hepatic
ischemia/reperfusion (ALT 11.39 and 23.42 %, AST
8.62 and 28.21 %, LDH 19.50 and 33.08 %, MDA
15.75 and 26.14 %, respectively) when compared to
IR-C group. In addition, these improvements materi-
alized partially and dose-dependently.
The same benefits with LYC at the doses of 2.5 and
5 mg/kg bw were observed by CAT activities. The
CAT activities were significantly increased (p \ 0.05)
in the LYC treated groups at the doses of 2.5 and 5 mg/kg
bw (62.01 and 90.50 %, respectively) as compared to the
IR-C group. Interestingly, these improvements material-
ized totally and dose-independently (Table 1).
Treatment of LYC at the doses of 2.5 and 5 mg/kg
bw markedly improved the ALT, AST, LDH, CAT
and MDA values as compared to the IR-C group
values (p \ 0.05). Especially; with respect to the CAT
levels, the values of the LYC tretament groups were
closer to those of the NC group (Table 1).
Discussion
Considerable evidence shows that ROS are involved in
the pathogenesis of hepatic I/R injury (Song et al.
2009). ROS changes carbohydrates, lipids and pro-
teins, as well as inactivates enzymes and transporters,
damages DNA and the transcriptional machinery, and
initiates the chain of reactions that peroxidize poly-
unsaturated fatty acids in membrane phospholipids
(Somi et al. 2009). Peroxidation of membrane lipids
can affect membrane fluidity and cell compartmenta-
tion, which can further lead to cell lysis. In fact, lipid
Table 1 Effects of ischemia–reperfusion and its treatment with lycopene (at the doses of 2.5 and 5 mg/kg bw) in the serum ALT,
AST, LDH and/or on hepatic MDA and CAT values
Groups9 ALT (U/L) AST (U/L) LDH (U/L) MDA (nmol/g protein) CAT (KU/g)
NC 47.32 ± 5.24 69.08 ± 5.83 125.42 ± 14.78 15.87 ± 1.02 6.79 ± 1.61
IR-C 386.40 ± 16.48a 416.47 ± 19.51a 858.38 ± 50.13a 30.03 ± 1.30a 3.58 ± 1.25a
LYC-2.5 342.36 ± 34.95a, b 380.54 ± 23.50a, b 690.97 ± 13.17a, b 25.30 ± 1.51a, b 5.80 ± 0.74a, b
LYC-5 295.89 ± 28.44a, b, c 298.97 ± 22.75a, b, c 574.40 ± 32.34a, b, c 22.18 ± 1.84a, b, c 6.82 ± 0.76b, c
3 For details see ‘‘Materials and methods’’ section. Data are mean ± SD values (n = 7). p \ 0.05, significantly different from a NC
group, b IR-C group and c LYC-2.5 with LYC-5 groups by Tukey’s multiple range tests
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peroxidation is implicated in the pathogenesis of
different liver injuries and subsequent liver fibrogen-
esis in humans and experimental animals. MDA is a
major reactive aldehyde that appears during the
peroxidation of the polyunsaturated fatty acids of
biological membrane. Therefore, the hepatic content
of it can be used as an indicator of liver tissue damage
(Bi et al. 2008). Interestingly, in our study, LYC
treatment caused a marked inhibition in MDA pro-
duction (Table 1). This decrease indicated that lipid
peroxidation of liver tissue and cellular injury was
reduced. The protective effect of LYC is most likely
due to its ability to scavenge the free radicals thereby
limiting liver damage.
For protection against the ROS generated during I/R
injury, liver tissues have developed an antioxidant
defense system. (Yu et al. 2005). Enzymes such as CAT
and SOD, act to remove oxygen free radicals (Polat
et al. 2008). CAT subsequently converts hydrogen
peroxide to water and oxygen. Removal of H2O2 by
CAT is significant in preventing lipid peroxidation of
membranes by OH radical. The role of it may be more
important during hyperoxic conditions than in norm-
oxic conditions (Yu et al. 2005). In our study, we found
that LYC at the doses of 2.5 and 5 mg/kg bw
administrated 60 min before initiation of ischemia
caused a substantial increasing in the I/R induced
decrease in CAT. Treatment of LYC was able to protect
against the decrease in the activity of this enzyme in the
I/R group (Table 1). These results demonstrate that
LYC can be used as a drug against hepatic damage
induced by I/R in favour of CAT activity.
ALT, AST, and LDH are generally used as markers
of cellular damage following hepatic I/R injury. In
some studies, it has been shown that the serum
concentrations of these enzymes increase in propor-
tion with the duration of ischemia (Kucuk et al. 2009).
In our study, treatment of LYC at the doses of 2.5 and
5 mg/kg bw decreased markedly the serum ALT, AST
and LDH levels as compared to IR-C group levels
(p \ 0.05) (Table 1). This result suggests that LYC
decreases hepatic cellular damage in favour of ALT,
AST and LDH activities.
In conclusion, the results of our study demonstrate
that lycopene has a protective effect against hepatic
I/R damage. The severity of hepatic I/R damage, as
evidenced by increased levels of AST, ALT, LDH,
MDA and decreased level of CAT, was alleviated by
LYC treatment. LYC with its potent free radical
scavenging and antioxidant properties seems to be a
promising agent in protecting liver against ischemia/
reperfusion injury.
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